At a glance
ClinicalIndex Comparison RecordN/ACompleted· 109 enrolled
Drug / intervention
Erchonia LUNULAdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Evaluation of the Effect of the Erchonia LUNULA on Treating Toenail Onychomycosis
In Brief
A clinical study evaluating Erchonia LUNULA for Onychomycosis. Completed, enrolled 109 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether low level laser light therapy is effective in the treatment of toenail onychomycosis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOnychomycosis
CountriesIreland
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2013
Primary CompletionFeb 2014
First PostedSep 2014
TodayJul 2026
First PostedSep 16, 2014
Enrollment StartFeb 1, 2013
Primary CompletionFeb 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 11.8 years ago
Interventions
Erchonia LUNULAdevice
The Erchonia LUNULA is administered to the infected toes for 12 minutes per treatment for 4 treatments, each treatment one week apart.